SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Science informs about ratings

22 Jan 2021 Evaluate

Strides Pharma Science has informed that India Ratings and Research (Ind-Ra) through its letter dated January 21, 2021 has upgraded company’s Long-Term Issuer Rating to ‘IND A+’ with a Stable Outlook from ‘IND A’ previously.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

1006.75 6.05 (0.60%)
20-Apr-2026 09:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.10
Dr. Reddys Lab 1229.95
Cipla 1240.55
Zydus Lifesciences 942.95
Lupin 2323.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×